In a move that is fated to incite political mutiny, Sens. Tom Coburn (R-Okla., left) and Richard Burr (R-N.C.) unveiled a bold Medicare reform proposal on Thursday that would expedite a transition to private health insurance, increase the eligibility age for oncoming seniors, and enact higher premiums for middle- to upper-class retirees.
America’s Roman Catholic bishops have joined other Christian and conservative voices in rejecting President Obama’s “compromise” on his earlier announced mandate requiring all employers — including most religious institutions — to include free contraception to women in their health insurance coverage.
Christian and pro-family groups are blasting President Obama’s “compromise” on his contraception mandate for religious groups as a meaningless distinction without a difference. On February 10, the White House announced that under a revision to the objectionable decree, religious institutions would not be required to offer free contraceptives to women employees as previously mandated. Instead, the requirement would be totally shifted to their insurance providers.
Former Massachusetts Governor Mitt Romney has lately been arguing strenuously against the Obama administration’s decision to force all employers, regardless of their religious convictions, to provide insurance coverage for contraception, including contraceptives that can cause abortions. The government's decision has been widely denounced by officials of the Roman Catholic and Orthodox churches because they are opposed to both birth control (except in certain limited circumstances) and abortion.
The press release issued by the U.S. Food and Drug Administration (FDA), which operates under the Department of Health and Human Services (HHS), on July 19, 2011, signaled the beginning of its regulatory process, this time concerning “mobile medical apps.” The announcement made it plain that such regulation certainly fell under its jurisdiction, as if declaring it made it so: “The use of mobile medical apps on smart phones and tablets is revolutionizing health care delivery,” according to Jeffrey Shuren, M.D., director of the FDA’s Center for Devices and Radiological Health. “Our draft approach calls for oversight of only those mobile medical apps that present the greatest risk to patients when they don’t work as intended.”